Physician

Joginder Soni, M.D.

According to 2025 Medicare claims, Joginder Soni, M.D. (NPI: 1598788622) practices cardiac electrophysiology in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is J. S. SONI, M.D., F.A.C.C. A PROFESSIONAL CORPORATION (NPI: 1104937572; TIN: 770504639) and primary practice location at 95382-2007.

Soni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 177 traditional Medicare patients, billed 8,705 HCPCS/CPT codes, and received $389,738 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,275 prescription claims across 155 beneficiaries totaling $445,388 in drug costs, led by Rybelsus (Semaglutide). DME data shows 87 claims. Open Payments data shows 15 records totaling $450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $488,330 and ending at $389,738. Concurrently, Part D prescription costs have risen steadily, from $257,428 to $445,388. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $23,951 and ending at $12,245.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	374	13,558	$488,330
2016	364	11,552	$496,876
2017	313	11,482	$398,828
2018	435	4,775	$261,542
2019	289	10,899	$407,548
2020	195	3,565	$285,214
2021	249	3,569	$282,527
2022	315	7,111	$357,432
2023	177	8,739	$349,449
2024	177	8,705	$389,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	6,074	$257,428
2016	281	6,132	$300,241
2017	267	5,649	$309,107
2018	254	4,176	$266,469
2019	237	4,415	$338,666
2020	189	4,121	$394,223
2021	172	3,879	$457,533
2022	199	3,696	$465,849
2023	165	2,784	$374,413
2024	155	3,275	$445,388

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	176	$21,275
2016	22	271	$13,172
2017	19	276	$8,569
2018	N/R	75	$2,109
2019	N/R	14	$756
2020	N/R	27	$9,431
2021	N/R	47	$11,692
2022	N/R	43	$12,033
2023	N/R	54	$12,566
2024	N/R	87	$13,557

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	130	398	$126
93923	Complete ultrasound study of arm and leg arteries	100	130	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	120	308	$88
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	141	285	$10
93040	Electrocardiogram (ecg) 1 to 3 leads with review by physician	140	274	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rybelsus	Semaglutide	77	2,970	$90,770
Jardiance	Empagliflozin	89	3,870	$69,694
Eliquis	Apixaban	71	2,610	$51,721
Repatha Sureclick	Evolocumab	68	2,004	$38,004
Vascepa	Icosapent Ethyl	74	3,210	$33,426

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$10,388
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	15	$1,213
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$981
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	17	$411
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	13	$336

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$450	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joginder Soni, M.D.?

Tedicare shows public-source Medicare data for Joginder Soni, M.D. (NPI 1598788622), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joginder Soni, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joginder Soni, M.D.?

Joginder Soni, M.D. is linked to J. S. SONI, M.D., F.A.C.C. A PROFESSIONAL CORPORATION (billing NPI 1104937572) in the available physician profile data.

Does Joginder Soni, M.D. have Open Payments data?

Joginder Soni, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.